Donepezil + Chromone + Melatonin Hybrids as Promising Agents for Alzheimer’s Disease Therapy

Journal of Enzyme Inhibition and Medicinal Chemistry - United Kingdom
doi 10.1080/14756366.2018.1545766
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Melatonin Therapy in Patients With Alzheimer’s Disease

Antioxidants
BiochemistryClinical BiochemistryCell BiologyMolecular BiologyPhysiology
2014English

Melatonin in Alzheimer’s Disease

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2013English

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease

Neurotherapeutics
NeurologyPharmacology
2017English

Imidazole Derivatives as Promising Agents for the Treatment of Chagas Disease†

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Effects of Cognitive-Communication Stimulation for Alzheimer’s Disease Patients Treated With Donepezil

Journal of Speech, Language, and Hearing Research
MedicineLinguisticsSpeechLanguageHearing
2004English

Fyn Kinase Inhibition as a Novel Therapy for Alzheimer’s Disease

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2014English

Gamma-Carbolines Derivatives as Promising Agents for the Development of Pathogenic Therapy for Proteinopathy

Acta Naturae
BiochemistryBiotechnologyMolecular MedicineMolecular Biology
2018English

Transition-Metal-Substituted Polyoxometalate Derivatives as Functional Anti-Amyloid Agents for Alzheimer’s Disease

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2014English

The Investigation of 2D Monolayers as Potential Chelation Agents in Alzheimer’s Disease

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy